cagrisema semaglutide Updates in Medicine | 🔬 REDEFINE 2: in T2D + Obesity Original article link in bio 👥 Phase 3a RCT in 1206 adults with T2D (BMI ≥27, HbA1c 7–10%) 💉 CAGRISEMA | peptidesskin

The PI3K/Akt pathway further increases glucose sensitivity in cells and promotes insulin secretion

Protective effect of geranylgeranylacetone via enhancement of HSPB8 induction in desmin-related cardiomyopathy

Tirzepatide is a newer medication that has shown greater results in weight loss

Unlike phentermine's fixed short-term window, semaglutide allows continuous treatment for months or years, making long-term weight loss maintenance possible

Peptide or compound Primary category What researchers study Status context Semaglutide GLP-1 / metabolic Appetite, glucose, and cardiometabolic signaling FDA-approved products exist for specific indications Tirzepatide GIP/GLP-1 / metabolic Appetite, glucose, and metabolic signaling FDA-approved products exist for specific indications Retatrutide Triple agonist / metabolic GLP-1, GIP, and glucagon receptor signaling Investigational BPC-157 Tissue-repair research Gastrointestinal, tendon, and angiogenesis pathways Research-only

Pediatr Res 2003 53:3